Key result
Antiphospholipid syndrome in SLE is linked to ~91% higher frequency of mitral regurgitation.
Why the study?
Echocardiographic changes in SLE patients with and without APS and their relation to disease activity and damage were not well characterized.
Observational (n=100)
Answers are grounded in this paper and cite their sources.
Observational study reveals elevated cardiac valve abnormalities in lupus patients with antiphospholipid syndrome, highlighting the necessity of early echocardiographic screening.
Aim of the work To assess the echocardiographic changes using Trans Thoracic Echocardiograghy in systemic lupus erythematosus (SLE) patients with and without antiphospholipid syndrome (APS) and to study the relation of the changes to the disease activity and damage. Patients and methods This study was conducted on 50 SLE patients (25 with and 25 without APS) and 50 controls. The SLE disease activity index (SLEDAI) and Systemic Lupus International Collaborating Clinics Damage index (SLICC/DI) were assessed. Laboratory investigations were performed and transthoracic echocardiography (TTE) was done. Results The mean age of the patients was 27.7 ± 8.5 years and disease duration 4.1 ± 3.7 years; 44 females and 6 males; 7.3:1. There was a high frequency of mitral (64%), aortic (22%) and tricuspid (24%) valve regurges as well as pericardial effusion (22%). Left ventricular hypertrophy and atrial dilation was present in 10% of the patients. The frequency of mitral, aortic and tricuspid regurge in SLE patients with APS tended to be higher (84%, 32% and 36%) than in those without (44%, 12% and 12%, respectively). There was a significant correlation between SLEDAI and pericardial effusion (p = 0.001), between the SLICC/DI with the left ventricular diastolic dysfunction (LVDD) (p = 0.001), the presence of lupus nephritis with the ejection fraction (p = 0.02) and between hypertension with the LVDD (p = 0.001). Conclusion All SLE patients especially those with APS should be screened for the presence of structural cardiac abnormalities. TTE can be helpful as a noninvasive diagnostic tool for early detection of the abnormalities, resulting in earlier treatment and reduction in mortality and morbidity.
No takes yet. Share an insight, caveat, or question.
Rady et al. (2017) conducted an observational in Systemic lupus erythematosus (n=100). Antiphospholipid syndrome (APS) vs. SLE without APS was evaluated on Mitral regurgitation. SLE patients with antiphospholipid syndrome had a higher frequency of mitral, aortic, and tricuspid regurgitation compared to those without.
Synapse has enriched 10 related papers. Consider them for comparative context: